Lindsy Solanki

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.

Cooley advised Kriya, a biopharmaceutical company, on the close of its Series C extension at more than $150 million in committed and raised capital, bringing the total Series C financing round to more than $430 million.

Cooley advised Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, on its $270 Million Series C financing round. Lawyers Lauren Creel and Lindsy Solanki led the Cooley team advising Kriya.

Cooley advised sustainable lifestyle brand Rothy’s in connection with its strategic investment from Brazilian footwear brand Alpargatas to fuel global growth and expand vertically integrated operations. The transaction will result in a post-investment valuation of $1 billion. Lawyers Jodie Bourdet, Al Browne, Lindsy Solanki, Farzad Tabaee and Meera Patel led the Cooley team advising Rothy’s.

Cooley advised parenting Cleo on its $27.5 million Series B financing. Cleo helps families navigate pregnancy and parenthood. Employers choose Cleo as a strategic partner to power culture transformation, increase employee retention, cultivate more diverse and inclusive workplaces and reduce health claims.